Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Equity

v3.24.1.u1
Condensed Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2022 $ 274,551 $ 4 $ 360,777 $ (85,188) $ (1,042)
Beginning balance (in shares) at Dec. 31, 2022   41,994,355      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (19,797)     (19,797)  
Other comprehensive loss, net of tax 4,404       4,404
Stock-based compensation 1,792   1,792    
Net share settlements of stock-based awards (405)   (405)    
Net share settlements of stock-based awards (in shares)   250,611      
Ending balance at Mar. 31, 2023 260,545 $ 4 362,164 (104,985) 3,362
Ending balance (in shares) at Mar. 31, 2023   42,244,966      
Beginning balance at Dec. 31, 2023 $ 251,690 $ 4 365,721 (123,284) 9,249
Beginning balance (in shares) at Dec. 31, 2023 42,853,468 42,853,468      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss $ (9,396)     (9,396)  
Other comprehensive loss, net of tax (9,612)       (9,612)
Stock-based compensation 1,763   1,763    
Net share settlements of stock-based awards (458)   (458)    
Net share settlements of stock-based awards (in shares)   205,073      
Ending balance at Mar. 31, 2024 $ 233,987 $ 4 $ 367,026 $ (132,680) $ (363)
Ending balance (in shares) at Mar. 31, 2024 43,058,541 43,058,541